Zenrock Promoter Pushes DOT Growth to 1,500 Tons

Indo Borax & Chemicals Limited — Q4 & FY2026 Earnings Call (held June 2, 2026)

1. Overall Tone of Management

Optimistic. Management repeatedly emphasizes “transformational phase,” “healthy profitability,” “robust demand,” and confidence in “sustainable growth and long-term value in FY27 and beyond.” They also give directional growth targets (e.g., revenue “Rs. 250-plus crore” next year) and express confidence in maintaining margins/quality of earnings.

2. Key Themes from Management Commentary

• Operational turnaround under new leadership/promoter transition
• Zenrock Chemicals becoming the new promoter; “new leadership team… took charge” in Q4.
• Value creation attributed to “capacity optimisation, improved operational efficiency, and better realisations.”
• Strong FY26 financial performance
• FY26: Operating revenue +22.9% to Rs. 215.45 cr; PAT +18% to Rs. 50.27 cr.
• EBITDA “nearly at par” with FY25 despite raw material/margin pressure.
• Capacity utilization and debottlenecking as the growth lever
• Boric Acid Technical “fully utilised” (capacity constraints are a key theme).
• DOT remains underutilized (capacity headroom), with plans to scale.
• Debottlenecking expected to add production days/volumes.
• Product mix shift toward higher value products
• Plan to increase DOT from ~980 tons to ~1,500 tons.
• Increase Boric Acid I.P. via interchange/debottlenecking; I.P. cited as 10–15% higher realisation.
• Boron Oxide project: first lot expected in 3–4 quarters.
• Raw material risk management / de-risking
• Boron ore sourcing concentration (Turkey historically) being reduced by expanding sourcing across Turkey, South America, North America.
• Capital allocation narrative
• Monetization of “non-core assets” leading to special dividend of Rs. 30/share (described as one-time).
• Management asserts cash remains available for CAPEX and future investment.

3. Q&A Analysis

Theme A: Product mix, capacity utilization, and growth roadmap

• Core questions
• Sales contribution by product (Boric Acid Technical, I.P., DOT, Boron Oxide).
• How much can volumes/revenue scale given current capacity constraints?
• Why DOT utilization is low and what changes are coming?
• Management response
• Boric Acid Technical dominates by volume; DOT is small but targeted for growth:
  • “Currently, 90%… Boric Acid… 8% is DOT… rest… 2%.”
  • DOT plan: “increase… to 50%,… close to 1,500 tons.”
• Boric Acid Technical is constrained: “Boric Acid is fully utilised.”
• DOT: management frames it as a “story of transformation,” focusing on customer/geography expansion; avoids blaming quality issues directly.
• Evasive/partial/strong points
• DOT low utilization: when asked about rejection/quality issues, management said: “I would not be able to say anything which was not our responsibility,” and did not provide concrete root-cause details.
• Peak turnover: provided ranges tied to raw material/pricing volatility rather than a fixed utilization-based model.

Theme B: Pricing, margins, and “quality of earnings”

• Core questions
• Why margins dipped in recent quarters (from prior 25–30% to ~20–22%).
• Whether EBITDA per kg can be maintained amid raw material volatility.
• How pricing is benchmarked (indices vs cost-plus/market-plus).
• Management response
• Margin explanation is largely confidence-based:
  • “We are confident of maintaining that or surpassing… 21%-22%.”
• Raw material volatility is argued to be less than other chemicals due to contracted/long-term inputs:
  • “I do not see we will have any issues… for at least a few quarters.”
• Pricing benchmarks: management states no global indices:
  • “In this industry there is no indices being used… purely based on… market… cost plus and then market plus and minus.”
• Evasive/partial/strong points
• Margin dip: they do not give a specific causal breakdown (e.g., product mix, costs, one-offs); instead they emphasize current stability and “quality of earnings.”
• Strong assertion: “we are not one of them” (not significantly impacted vs other chemical players) without quantified evidence in the transcript.

Theme C: New-age applications, export strategy, and Boron Oxide timeline

• Core questions
• Plans to supply to electronics/semiconductor/defense/other new-age applications.
• Boron Oxide project timeline and potential revenue.
• Export market approach.
• Management response
• New applications: “exploratory stage,” more confident “next or next-to-next quarter.”
• Boron Oxide timeline: “first lot in three to four quarters.”
• Revenue potential: cautious, pricing-dependent; Boron Oxide described as 2x–3x price of Boric Acid (revenue “accordingly”).
• Evasive/partial/strong points
• New-age applications: explicitly deferred (“exploratory… more confident… next quarter”).
• Export: discussed as “working on it” but without concrete targets, geographies, or timelines.

Theme D: Zenrock acquisition rationale, dividend vs reinvestment, and governance

• Core questions
• Why acquire a historically underperforming growth asset; what attracted Zenrock?
• Logic behind special dividend immediately after takeover (cash out vs reinvestment).
• Any leverage/pledging risk (loan-to-value, promoter share pledge).
• Management response
• Acquisition rationale: “strong company… zero-debt… very strong balance sheet with sufficient cash available to do CAPEX.”
• Dividend logic: monetized “non-core assets” (flats/cars) and distributed to “new promoters and old shareholders.”
• Pledge/debt: management states “We have zero debt in Indo Borax.” (However, one participant claimed Rs.400 cr debt; management did not reconcile in detail in the transcript.)
• Evasive/partial/strong points
• Dividend vs reinvestment: narrative is coherent but still leaves ambiguity on how much cash remains and exact CAPEX quantum (details “post board approval”).
• Debt/pledge: potential inconsistency—participant asserts debt exists; management redirects to IR for exact LTV, while also stating “zero debt.”

Theme E: Raw material sourcing concentration and de-risking

• Core questions
• How to compete given Turkey’s crude boron monopoly/control.
• What is the de-risking plan?
• Management response
• They acknowledge ore sourcing from Turkey historically but are de-risking:
  • “working very strongly… de-risk ourselves from any dependence on one particular location.”
• Harsh Malhotra: boron ore found in only three places; focus is expanding purchasing across US, South America, Turkey.
• Evasive/partial/strong points
• No quantified sourcing mix or contract terms were provided.

4. Guidance / Outlook

Explicit guidance (quantitative / semi-quantitative)

• FY26 results (historical, not guidance):
• Q4 FY26 revenue Rs. 63.01 cr; PAT Rs. 14.53 cr.
• FY26 revenue Rs. 215.45 cr; PAT Rs. 50.27 cr.
• FY27 / coming year directional targets (management commentary)
• Revenue: “expect to reach Rs. 250-plus crore of revenue in the coming year.”
• Revenue growth range: “moving between 20% to 35% of revenue growth.”
• EBITDA margin: desire to “maintain exactly the same level of quality of earnings or EBITDA percentage… in this quarter.”
• DOT volume: from ~980 tons to ~1,500 tons (and “increase… to 50%” utilization).
• Boron Oxide: “first lot in three to four quarters.”
• Boric Acid incremental volume via efficiencies: “increase 1,000 tons to 1,500 tons” (operational efficiency / planned shutdown improvements).
• Dividend policy
• No fixed payout policy yet: “in the process of making a stated dividend policy… not declared yet.”

Implicit signals (qualitative)

• Margins: confidence that EBITDA% will not correct downward: “no corrections… maintain… for a few quarters.”
• Demand: “no complaints… happy with our results in April,” and Q1 expected to be “nowhere less than our Quarter 4 earnings.”
• Strategy: “story of transformation,” “strategy continues to be on track,” and “CAPEX plans… expand capacity and broaden product portfolio” (details pending board approval).

5. Standout Statements (most revealing)

• Capacity constraint + growth lever
• “Boric Acid is fully utilised… DOT is where our volumes are still to be utilised a lot more.”
• Revenue outlook tied to pricing volatility
• “expect to reach Rs. 250-plus crore… But again, revenue is always a function of raw material fluctuations and inflation.”
• Margin confidence without detailed causal explanation
• “We are confident of maintaining that or surpassing… 21%-22%.”
• Raw material de-risking
• “de-risk ourselves from any dependence on one particular location.”
• Dividend rationale
• “non-core assets… sold… resulting in an additional one-time reward as a special dividend of Rs. 30 per equity share.”
• No global pricing index
• “there is no indices being used… purely based on… cost plus and then market plus and minus.”
• DOT utilization root-cause avoidance
• “I would not be able to say anything which was not our responsibility” (when asked about why DOT is underutilized).

6. Red Flags / Positive Signals

Red flags
– Limited transparency on margin drivers: management attributes margin stability to confidence/contracting but does not provide a clear bridge from prior margin dip to current stability.
– DOT underutilization explanation is non-specific: refusal to discuss potential quality/rejection reasons.
– Potential inconsistency on debt/pledging: participant claims Rs.400 cr debt; management says “zero debt” and redirects LTV details to IR—no reconciliation in transcript.
– Export/new applications deferred: “exploratory stage” and confidence deferred to “next quarter,” with no measurable milestones.

Positive signals
– Clear operational levers: debottlenecking, shutdown planning, and volume ramp plans are described concretely.
– Risk management narrative: sourcing de-risking across geographies is explicitly discussed.
– Customer stickiness claim: “top 10 to 15 customers have been same for many years,” implying quality/relationship strength.
– Cash + balance sheet strength emphasized: “near-zero debt” / “zero-debt” narrative supports funding flexibility.

7. Historical Comparison & Consistency Analysis

Note: No prior earnings call transcripts were provided (“No documents matched the configured filters”). Therefore, historical comparison across calls cannot be performed.

a. Change in Tone Over Time

• Not assessable (no prior transcripts available).

b. Tracking Past Commitments vs Outcomes

• Not assessable (no prior transcripts available).

c. Narrative Shifts

• Not assessable (no prior transcripts available).

d. Consistency & Credibility Signals

• Medium credibility (based on this call alone):
• Strong confidence statements, but some answers are deferred or non-specific (DOT utilization, export/new applications, margin dip causality).
• Dividend vs reinvestment logic is coherent, but CAPEX specifics are withheld (“post board approval”).

e. Evolution of Key Themes

• Not assessable across time; within this call:
• Themes emphasize transformation, product mix shift (DOT/I.P./Boron Oxide), and raw material de-risking.

f. Additional Insights (Cross-Period Intelligence)

• Not assessable without prior transcripts.